CIK 0001953926
- Emerging growth company
Zenas BioPharma, Inc.
Sign in to watch- Ticker
- ZBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 857-271-2954
- Business address
- 852 WINTER STREET, SUITE 250, WALTHAM, MA, 02451
- Former names
- Zenas BioPharma (Cayman) Ltd
- 4 Open-market buy Director bought 440,000 shares at $17.00 ($7,480,000)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 882,352 shares at $17.00 ($14,999,984)
- 4 Open-market buy Director bought 300,000 shares at $17.00 ($5,100,000)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy 10% owner bought 2,235,294 shares at an average $17.00 ($37,999,998)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Conversion Chief Executive Officer acquired 693,175 shares (conversion)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
Page 4 of 5 · 84 filings